These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Permeability of the hemato-encephalic barrier to antibiotics in patients with infectious meningitis]. Mosiĭchuk NM Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(3):338-42. PubMed ID: 4872691 [No Abstract] [Full Text] [Related]
5. [The value of cerebrospinal fluid lactate assay in meningitis]. Tolboom J; Willems J; Monnens L Ned Tijdschr Geneeskd; 1980 Apr; 124(17):644-7. PubMed ID: 7383174 [No Abstract] [Full Text] [Related]
6. [Intrathecal use of antibiotics in childhood]. Nigro N Minerva Pediatr; 1982 Feb; 34(3):135-6. PubMed ID: 6896228 [No Abstract] [Full Text] [Related]
7. [Significance of monomycin concentration in the cerebrospinal fluid in the treatment of experimental purulent meningitis]. Mosiĭchuk NM Zh Eksp Klin Med; 1969; 9(5):47-51. PubMed ID: 4913233 [No Abstract] [Full Text] [Related]
8. [Antibiotics, particularly relating to treatment of purulent meningitis (author's transl)]. Kobayashi Y; Haruta T No Shinkei Geka; 1981 Jun; 9(7):771-83. PubMed ID: 7022250 [No Abstract] [Full Text] [Related]
9. [Quantitative chloramphenicol detection in serum and cerebrospinal fluid of infants with bacterial meningitis]. Köhler E; Klaer U; Meyer FP; Walther H Kinderarztl Prax; 1991; 59(1-2):38-43. PubMed ID: 2056660 [TBL] [Abstract][Full Text] [Related]
10. [Antibacterial activity of the cerebrospinal fluid during antibiotic therapy (50 cases of meningitis)]. Turcu T; Vâţă A; Grigoriu A; Cuciureanu G; Râpeanu E; Mihalache D; Danilă F Rev Med Chir Soc Med Nat Iasi; 1977; 81(2):193-200. PubMed ID: 905675 [No Abstract] [Full Text] [Related]
11. A review of the penetration of antibiotics into CSF and its clinical significance. Norrby R Scand J Infect Dis Suppl; 1978; (14):296-309. PubMed ID: 30168 [No Abstract] [Full Text] [Related]
12. [Penetration of antibiotics into the cerebrospinal fluid. Theoretical and practical aspects (author's transl)]. Modai J Nouv Presse Med; 1980 Dec; 9(47):3615-20. PubMed ID: 6937071 [TBL] [Abstract][Full Text] [Related]
13. [Antibiotic therapy of purulent meningitis]. Sansonetti PJ; Dupont B Ann Med Interne (Paris); 1986; 137(5):369-71. PubMed ID: 3813266 [No Abstract] [Full Text] [Related]
14. [Control of the effectiveness of antibiotic therapy by determining the antibacterial activity of the blood and cerebrospinal fluid]. Căruntu F Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1982; 27(2):127-30. PubMed ID: 7146758 [TBL] [Abstract][Full Text] [Related]
16. Strategies and new developments in the management of bacterial meningitis. Miranda J; Tunkel AR Infect Dis Clin North Am; 2009 Dec; 23(4):925-43, viii-ix. PubMed ID: 19909891 [TBL] [Abstract][Full Text] [Related]
17. [The cerebrospinal fluid concentration of lamoxactam with reference to the therapy of gram-negative CNS infections]. Nix WA; Hey O; Fabricius K Nervenarzt; 1982 Dec; 53(12):693-700. PubMed ID: 6218415 [No Abstract] [Full Text] [Related]
18. [Bacterial meningitides. Viewpoints on diagnosis and therapy]. Olischer RM Z Arztl Fortbild (Jena); 1975 Dec; 69(24):1249-55. PubMed ID: 1216929 [No Abstract] [Full Text] [Related]
19. Treatment of central nervous system infections in small animals. Fenner WR J Am Vet Med Assoc; 1984 Nov; 185(10):1176-80. PubMed ID: 6392251 [No Abstract] [Full Text] [Related]
20. Antibiotic therapy of bacterial meningitis: lessons we've learned. Sande MA Am J Med; 1981 Oct; 71(4):507-10. PubMed ID: 7282738 [No Abstract] [Full Text] [Related] [Next] [New Search]